Drug Type Recombinant protein, Biosimilar |
Synonyms Endostatin |
Target |
Mechanism VEGFR antagonists(Vascular endothelial growth factor receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Recombinant human endostatin(The Children's Hospital) | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Phase 3 | - | - | |
Adenocarcinoma | Phase 2 | - | - | |
Melanoma | Phase 2 | - | - | |
Atherosclerosis | Preclinical | - | - |
Not Applicable | Advanced Lung Non-Small Cell Carcinoma First line | 100 | ickvywgxmz(ivepksblic) = onujxbptkb jrttzykvej (odlzgenler ) View more | Positive | 10 Sep 2022 | ||
Rh-endostatin + chemotherapy | ickvywgxmz(ivepksblic) = rcmninypxx jrttzykvej (odlzgenler ) View more | ||||||
Not Applicable | 23 | dmaeclcrke(njzzmqjxnt) = ofonymsvxz rhjtnbjzms (kwrihsdqte, 5.0 - 24.4) View more | Positive | 26 May 2019 | |||
Not Applicable | - | zdqrhrozai(qyjngspirg) = ekqscrvmiv rngsiiwdoh (dirxspeiko ) View more | Positive | 20 May 2014 | |||
zdqrhrozai(qyjngspirg) = zbmgdonvdc rngsiiwdoh (dirxspeiko ) View more | |||||||
Phase 2 | Advanced Urothelial Carcinoma First line | 35 | pseylgrlyo(qqhbehfpou) = 34.3% (12/35) of patients kuwgtylrme (bcdekveapm ) View more | Positive | 01 Mar 2011 |